Lymphokines as inhibitors of hematopoietic cell proliferation.
Although the identification of lymphokines negatively affecting hematopoiesis is rapidly increasing, efforts to precisely define their action even in vitro have become more and more complicated. Studies of lymphokine abnormalities in aplastic anemia exemplify the modest contribution of experimental hematology to permit access to possible pathogenic mechanisms of hematopoietic failure syndromes. Nevertheless, these results help in the interpretation of clinical observations and to develop alternative therapeutic concepts.
Raghavachar
A
A
Department of Internal Medicine III, University of Ulm, Federal Republic of Germany.
Frickhofen
N
N
Digel
W
W
Porzsolt
F
F
Heimpel
H
H
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects; D006801:Humans; D008222:Lymphokines / Q000494:pharmacology / Q000502:physiology*; D011994:Recombinant Proteins / Q000494:pharmacology
D008222:Lymphokines; D011994:Recombinant Proteins